MX2010005193A - Proceso para la preparacion de derivados de 2h-cromen-3-carbamato. - Google Patents
Proceso para la preparacion de derivados de 2h-cromen-3-carbamato.Info
- Publication number
- MX2010005193A MX2010005193A MX2010005193A MX2010005193A MX2010005193A MX 2010005193 A MX2010005193 A MX 2010005193A MX 2010005193 A MX2010005193 A MX 2010005193A MX 2010005193 A MX2010005193 A MX 2010005193A MX 2010005193 A MX2010005193 A MX 2010005193A
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- alkyl
- compounds
- alkylcarbonylamino
- alkyloxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98746707P | 2007-11-13 | 2007-11-13 | |
| US8592708P | 2008-08-04 | 2008-08-04 | |
| PCT/PT2008/000048 WO2009064210A2 (en) | 2007-11-13 | 2008-11-13 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010005193A true MX2010005193A (es) | 2010-06-02 |
Family
ID=40550012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010005193A MX2010005193A (es) | 2007-11-13 | 2008-11-13 | Proceso para la preparacion de derivados de 2h-cromen-3-carbamato. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100298580A1 (enExample) |
| EP (1) | EP2217585A2 (enExample) |
| JP (1) | JP2011503175A (enExample) |
| KR (1) | KR20100102606A (enExample) |
| CN (1) | CN101952271A (enExample) |
| AR (1) | AR069311A1 (enExample) |
| AU (1) | AU2008321625A1 (enExample) |
| BR (1) | BRPI0818105A2 (enExample) |
| CA (1) | CA2705512A1 (enExample) |
| MX (1) | MX2010005193A (enExample) |
| RU (1) | RU2010123778A (enExample) |
| TW (1) | TW200927740A (enExample) |
| WO (1) | WO2009064210A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201316410D0 (en) | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
| US11875700B2 (en) | 2014-05-20 | 2024-01-16 | Jessica Robinson | Systems and methods for providing communication services |
| CN110590728B (zh) * | 2019-10-15 | 2022-03-22 | 青岛科技大学 | 一种多取代4-苯基色满类化合物的合成方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0232279B2 (ja) * | 1982-08-12 | 1990-07-19 | Kowa Co | Jihidorobenzopiranjioorunoseiho |
| SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
| EP0757677B1 (en) * | 1994-04-26 | 2003-06-18 | Syntex (U.S.A.) LLC | Benzocyclohexylimidazolethione derivatives |
| US6867224B2 (en) * | 2002-03-07 | 2005-03-15 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods of preparation |
| JP2004075614A (ja) * | 2002-08-20 | 2004-03-11 | Sankyo Co Ltd | クロメン誘導体を含有する医薬 |
| US7125904B2 (en) * | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| US20050032873A1 (en) * | 2003-07-30 | 2005-02-10 | Wyeth | 3-Amino chroman and 2-amino tetralin derivatives |
| US20050245489A1 (en) * | 2004-05-03 | 2005-11-03 | Pinney Kevin G | Chromene-containing compounds with anti-tubulin and vascular targeting activity |
| US7456214B2 (en) * | 2004-05-03 | 2008-11-25 | Baylor University | Chromene-containing compounds with anti-tubulin and vascular targeting activity |
| NZ552173A (en) * | 2004-06-25 | 2010-07-30 | Janssen Pharmaceutica Nv | Quaternary salt CCR2 antagonists |
| CN101068801B (zh) * | 2004-10-14 | 2012-11-14 | 艾博特股份有限两合公司 | 适用于治疗对于多巴胺d3受体的调节有反应的疾病的芳基磺酰基甲基或芳基磺酰胺取代的芳族化合物 |
| CN101365682A (zh) * | 2005-12-08 | 2009-02-11 | 千禧药品公司 | 具有激酶抑制活性的双环化合物 |
| AR064308A1 (es) * | 2006-12-12 | 2009-03-25 | Portela & Ca Sa | Proceso de obtencion de cromanos, los mencionados compuestos, un intermediario para su sintesis, un metodo de sintesis de croman-3-il-dihidroimidazol-2-tiona que los emplea, un complejo de metales de transicion derivado de fosfin-bipiridina y su uso como catalizador. |
-
2008
- 2008-11-12 TW TW097143774A patent/TW200927740A/zh unknown
- 2008-11-13 US US12/742,738 patent/US20100298580A1/en not_active Abandoned
- 2008-11-13 CA CA2705512A patent/CA2705512A1/en not_active Abandoned
- 2008-11-13 JP JP2010533987A patent/JP2011503175A/ja active Pending
- 2008-11-13 MX MX2010005193A patent/MX2010005193A/es not_active Application Discontinuation
- 2008-11-13 EP EP08850447A patent/EP2217585A2/en not_active Withdrawn
- 2008-11-13 KR KR1020107012805A patent/KR20100102606A/ko not_active Withdrawn
- 2008-11-13 RU RU2010123778/04A patent/RU2010123778A/ru unknown
- 2008-11-13 BR BRPI0818105A patent/BRPI0818105A2/pt not_active IP Right Cessation
- 2008-11-13 AR ARP080104958A patent/AR069311A1/es unknown
- 2008-11-13 CN CN2008801246552A patent/CN101952271A/zh active Pending
- 2008-11-13 WO PCT/PT2008/000048 patent/WO2009064210A2/en not_active Ceased
- 2008-11-13 AU AU2008321625A patent/AU2008321625A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200927740A (en) | 2009-07-01 |
| WO2009064210A3 (en) | 2009-12-30 |
| CN101952271A (zh) | 2011-01-19 |
| RU2010123778A (ru) | 2011-12-20 |
| CA2705512A1 (en) | 2009-05-22 |
| BRPI0818105A2 (pt) | 2019-09-24 |
| KR20100102606A (ko) | 2010-09-24 |
| EP2217585A2 (en) | 2010-08-18 |
| JP2011503175A (ja) | 2011-01-27 |
| AU2008321625A1 (en) | 2009-05-22 |
| WO2009064210A2 (en) | 2009-05-22 |
| US20100298580A1 (en) | 2010-11-25 |
| AR069311A1 (es) | 2010-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY172034A (en) | Intermediate for producing bicyclic ?-amino acid derivative | |
| PH12012501000A1 (en) | Novel tricyclic compounds | |
| WO2008114817A1 (ja) | 新規なアデニン化合物 | |
| MX2011008176A (es) | Derivados de 3,3'-espiroindolinona como agentes anticancerigenos. | |
| GB0719180D0 (en) | New process | |
| WO2009079008A8 (en) | Benzopyrans and analogs as rho kinase inhibitors | |
| MY148636A (en) | Benzimidazole derivatives | |
| TW201002720A (en) | Novel tricyclic compounds | |
| NZ599040A (en) | 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6h)-one compounds for selective inhibitors of lrrk2 and syk kinases | |
| PH12012501162A1 (en) | Novel antiplatelet agent | |
| EP1852434A4 (en) | BICYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING INHIBITION OF HIV INTEGRASE ACTIVITY | |
| WO2007079186A3 (en) | 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors | |
| WO2008146871A1 (ja) | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規１，２，３，４－テトラヒドロキノキサリン誘導体 | |
| IN2014CN00532A (enExample) | ||
| WO2009057811A3 (en) | Heterocyclic compound and pharmaceutical composition thereof | |
| EA201190216A1 (ru) | Производные рифамицина | |
| WO2008006969A3 (fr) | Nouveaux derives tetracycuques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| JO2616B1 (ar) | مركبات ثلاثية الحلقات جديدة، طريقة من أجل تحضيرها ومركباتها الصيدلانية | |
| GB2454629A (en) | Pyrrolo[2, 1-C][1, 4]benzodiazepine hybrids and a process for the preparation thereof | |
| MY138466A (en) | Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders | |
| MX2010005193A (es) | Proceso para la preparacion de derivados de 2h-cromen-3-carbamato. | |
| WO2010080795A8 (en) | Hydrogen peroxide complexes and their use in the cure system of anaerobic adhesives | |
| GB0428416D0 (en) | Organic compounds | |
| EA201001252A1 (ru) | Способ получения производных 3,6-дигидро-1,3,5-триазина | |
| EP2604261A3 (en) | SCCA-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |